Biochemical detection of novel anaplastic lymphoma kinase proteins in tissue sections of anaplastic large cell lymphoma

American Journal of Pathology

Volumn 154, Issue 6, 1999, Pages 1657-1663

  Pulford, Karen ^a   Falini, Brunangelo ^b   Cordell, Jaqueline ^a   Rosenwald, Andreas ^c   Ott, German ^c   Müller Hermelink, Hans Konrad ^c   MacLennan, Kenneth A ^d   Lamant, Laurence ^e   Carbone, Antonio ^f   Campo, Elias ^g   Mason, David Y ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF PERUGIA   (Italy)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^e CHU PURPAN   (France)

^f CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^g UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN KINASE;

AMINO TERMINAL SEQUENCE; ANAPLASTIC CARCINOMA; ARTICLE; CHROMOSOME TRANSLOCATION 2; CHROMOSOME TRANSLOCATION 3; CHROMOSOME TRANSLOCATION 5; ENZYME ACTIVITY; ENZYME ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; LARGE CELL LYMPHOMA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0033028727     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65421-1     Document Type: Article

References (31)

1. Morris SW, Kirstein MN, Valentine MB, Dittmer KG, Shapiro DN, Saltman DI, Look AT: Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science 1994, 263: 1281-1284
2. Borer RA, Lehner CF, Eppenberger HM, Nigg EA: Major nucleolar proteins shuttle between nucleus and cytoplasm. Cell 1989, 56:379-390
3. Pulford K, Lamant L, Morris SW, Butler LH, Wood KM, Stroud D, Delsol G, Mason DY: Detection of anaplastic lymphoma kinase (ALK) and nucleolar protein nucleophosmin (NPM)-ALK proteins in normal and neoplastic cells with the monoclonal antibody ALK1. Blood 1997, 89:1394-1404
4. Iwahara T, Fujimoto J, Wen D, Cupples R, Bucay N, Arakawa T, Mori S, Ratzkin B, Yamamoto T: Molecular characterization of ALK, a receptor tyrosine kinase expressed specifically in the central nervous system. Oncogene 1997, 14:439-449
5. Morris SW, Naeve C, Mathew P, James PL, Kirstein MN, Cui X, Witte DP: ALK, the chromosome 2 gene locus altered by the t(2;5) in non-Hodgkin's lymphoma, encodes a novel neural receptor tyrosine kinase that is highly related to leukocyte tyrosine kinase LTK. Oncogene 1997, 14: 2175-2188
6. Shiota M, Fujimoto J, Semba T, Satoh H, Yamamoto T, Mori S: Hyperphosphorylation of a novel 80 kd protein tyrosine kinase similar to Ltk in a human Ki-1 lymphoma cell line, AMS3. Oncogene 1994, 9:1567-1574
7. Fujimoto J, Shiota M, Iwahara T, Seki H, Satoh H, Mori S, Yamamoto T: Characterisation of the transforming activity of p80, a hyperphosphorylated protein in a Ki-1 lymphoma cell line with chromosomal translocation t(2;5). Proc Natl Acad Sci USA 1996, 93:4181-4186
8. Bischof D, Pulford K, Mason DY, Morris SW: Role of the nucleophosmin (NPM) portion of the non-Hodgkin's lymphoma-associated NPM-anaplastic lymphoma kinase fusion protein in oncogenesis. Mol Cell Biol 1997, 17:2312-2325
9. Kuefer MU, Look AT, Pulford K, Behm FG, Pattengale PK, Mason DY, Morris SW: Retrovirus-mediated gene transfer of NPM-ALK causes lymphoid malignancy in mice. Blood 1997, 90:2901-2910
10. Mason DY, Pulford KAF, Bischof D, Kuefer MU, Butler LH, Lamant L, Delsol G, Morris SW: Nucleolar localization of the nucleophosminanaplastic lymphoma kinase is not required for malignant transformation. Cancer Res 1998, 58:1057-1062
11. Shiota M, Fujimoto J, Takenaga M, Satoh H, Ichinohasama R, Abe M, Nakano M. Yamamoto T, Mori S: Diagnosis of t(2;5)(p23;q35)-associated Ki-1 lymphoma with immunohistochemistry. Blood 1994, 84: 3648-3652
12. Lamant L, Meggetto F, Al Saati T, Brugieres L: Bressac de Paillerets B, Dastugue N, Bernheim A, Rubie H, Terrier-Lacombe MJ, Robert A, Brousset P, Rigal F, Schlaifer D, Shiota M, Mori S, Delsol G: High incidence of the t(2;5)(p23;q35) translocation in anaplastic large cell lymphoma and its lack of detection in Hodgkin's disease. Comparison of cytogenetic analysis, reverse transcriptase-polymerase chain reaction, and P-80 immunostaining. Blood 1996, 87:284-291
13. Falini B, Bigerna B, Fizzotti M, Pulford K, Pileri SA, Delsol G, Carbone A, Paulli M, Magrini U, Menestrina F, Giardini R, Pilotti S, Mezzelani A, Ugolini B, Billi M, Pucciarini A, Pacini R, Pelicci P-G, Flenghi L: ALK expression defines a distinct group of T/Null lymphomas (ALK lymphoma) with a wide morphological spectrum. Am J Pathol 1998, 153:875-886
14. Benharroch D, Meguerian-Bedoyan Z, Lamant L, Amin C, Brugieres L, Terrier-Lacombe MJ, Haralambieva E, Pulford K, Pileri S, Morris SW, Mason DY, Delsol G: ALK-positive lymphoma: a single disease with a broad spectrum of morphology. Blood 1998, 91:2076-2084
15. Rosenwald A, Ott G, Pulford K, Katzenberger T, Kuhl J, Kalla J, Ott MM, Mason DY, Muller-Hermelink HK: t(1;2)(q21;p23): Two novel variant translocations of the t(2;5)(p23:q35) in anaplastic large cell lymphoma. Blood in press
16. Pittaluga S. Wlodarska I, Pulford K, Campo E, Morris SW: Van den Berghe H, De Wolf-Peeters C: The monoclonal antibody ALK1 identifies a distinct morphological subtype of anaplastic large cell lymphoma associated with 2p23/ALK rearrangements. Am J Pathol 1997, 151:343-351
17. Wodarska I, De Wolf-Peeters C, Falini B, Verhoef G, Morris SW, Hagemeijer A: Van den Berghe H: The cryptic inv(2)(p23q35) defines a new molecular genetic subtype of ALK-positive anaplastic large-cell lymphoma. Blood 1998, 92:2688-2695
18. Sainati L, Montaldi A, Stella M, Putti MC, Zanesco L, Basso G: A novel variant translocation t(2;13)(p23;q34) in Ki-1 large cell anaplastic lymphoma. Br J Haematol 1990, 75:621-622
19. Mitev L, Christova S. Hadjiev E, Guenova M, Oucheva R, Valkov I, Manolova Y: A new variant chromosomal translocation t(2:2)(p23; q23) in CD30+/Ki-1+ anaplastic large cell lymphoma. Leuk. Lymphoma 1998, 28:613-616
20. Park JP, Curran MJ, Levy NB, Davis TH, Elliott JH, Mohandas TK: Diffuse large cell, B-cell type lymphoma with a novel translocation (2;22)(p23;q11.2). Cancer Genet Cytogenet 1997, 96:118-122
21. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JKC, Cleary ML, Delsol G, De Wolf-Peeters C, Falini B, Gatter KC, Grogan TM, Isaacson PG, Knowles DM, Mason DY, Müller-Hermelink HK, Pileri SA, Piris MA, Ralfkaier E, Warnke RA: A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 1994, 84:1361-1392
22. Cordell JL, Pulford KAF, Bigerna B, Roncador G, Banham A, Colombo E, Pelicci P-G, Mason DY, Falini B: Detection of normal and chimaeric nucleophosmin in human cells. Blood 1998, 93:632-642
23. Cordell JL, Falini B, Erber WN, Ghosh AK, Abdulaziz Z, MacDonald S, Pulford KAF, Stein H, Mason DY: Immunoenzymatic labelling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem 1984, 32:219-229
24. Pileri S, Roncador G, Ceccarelli C, Piccioli M, Briskomatis A, Sabattini E, Ascani S, Santini D, Piccaluga PP, Leone O, Damiani S, Ercolessi C, Sandri F, Pieri F, Leoncini L, Falini B: Antigen retrieval techniques in immunohistochemistry: comparison of different methods. J Pathol 1997, 183:116-123
25. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685
26. Falini B, Pulford K, Carbone A, Cordell J, Fizzotti M, De Wolf-Peeters C. Santucci A, Pelicci P-G, Pileri S, Mason DY: Lymphomas expressing ALK fusion protien(s) other than NPM-ALK. Blood in press
27. Lamant L, Nicole N, Pulford K, Delsol G, Bernard M: A new fusion gene TPM3-ALK in anaplastic large cell lymphoma created by a (1;2)(q25;p23) translation Blood in press
28. Martin-Zanca D, Hughes SH, Barbacid M: A human oncogene formed by the fusion of truncated tropomyosin and protein tyrosine kinase sequences. Nature 1986, 319:743-748
29. Butti MG, Bongarzone I, Ferraresi G, Mondellini P, Borello MG, Pierotti MA: A sequence analysis of the genomic regions involved in the rearrangements between TPM3 and NTRK1 genes producing TRK oncogenes in papillary thyroid carcinomas. Genomics 1995, 28: 15-24
30. Grigg AP, Gascoyne RD, Phillips GL, Horsman DE: Clinical, haematological, and cytogenetic features in 24 patients with structural rearrangements of the Q arm of chromosome 3. Br J Haematol 1993, 83:158-165
31. Yamagata N, Shimazaki C, Kikuta T, Hirai H, Sumikuma T, Sudo Y, Ashihara E, Goto H, Inaba T, Fujita N, Nakagawa M: A translocation between 3q21 and 12q24 in a patient with minimally differentiated acute myeloid leukaemia (AML-MO). Cancer Genet Cytogenet 1997, 97:90-93